KCAS Bio will be attending the ACT Annual Meeting on November 15th – 18th in San Antonio, Texas.
The ACT Meeting gathers the toxicology community for four days of scientific exchange, networking, and professional development. With a strong focus on applied toxicology, the meeting features a robust scientific program, including symposia, workshops, continuing education courses, and poster presentations.
Applications of Toxicology at KCAS Bio
As a leading bioanalytical CRO, KCAS Bio provides specialized services that support non-clinical safety assessment and toxicology research. Our team develops and validates assays for toxicokinetic analysis, immunogenicity testing, and biomarker analysis. With these developments, KCAS Bio provides robust and reproducible data that can characterize drug exposure, evaluate immune responses, and identify early biomarkers for toxicity. Through precise, validated methods and a commitment to scientific integrity, we deliver data-driven insights that inform risk assessment and regulatory decision-making in preclinical development.
Meet With Us
Connect with KCAS Bio during the ACT Annual Meeting to discuss our expertise in bioanalysis and molecular services. Our team will be attending, and we look forward to discussing how we can support your ongoing or future studies.